Tag: business

Bringing together Elektrobit's software platform and AUTOCRYPT's cybersecurity engineering expertise Advancing software-defined mobility innovation through strategic collaboration SEOUL, South Korea, June 25, 2026 /PRNewswire/ -- AUTOCRYPT, a leading...

Native video, custom audience targeting, and real-time optimization helped GUESS FRAGRANCES beat engagement benchmarks during one of advertising's most competitive momentsCANNES, France, June 25,...

KNL, owned by Telenor Group, has been appointed as an approved supplier on the United Kingdom's Tactical Communication Systems Framework

Proposed Strategic Business Public Company at $575 Million Initial Enterprise Value with Significant Long Term Growth Potential Through Strategic Acquisitions

Proposed Strategic Business Public Company at $575 Million Initial Enterprise Value with Significant Long Term Growth Potential Through Strategic Acquisitions

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Futu Holdings Limited (NASDAQ: FUTU) resulting from allegations that Futu may have issued materially misleading business information to the investing public.

TAIPEI, June 25, 2026 /PRNewswire/ -- Led by the Department of Economic Development, Taipei City Government, the StartUP@Taipei program brought 10 Taipei-based AI companies...

SAN FRANCISCO, June 24, 2026 /PRNewswire/ -- The global digital health market is expected to witness significant expansion over the coming years, with the...

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Graphic Packaging Holding Company (NYSE: GPK) between February 4, 2025 and February 2, 2026, inclusive (the “Class Period”), of the important July 6, 2026 lead plaintiff deadline.

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

TORONTO, June 24, 2026 /CNW/ - Jamieson Wellness Inc. ("Jamieson" or the "Company") (TSX: JWEL) acknowledges a recent media report regarding a potential sale...

RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (Nasdaq: CDNL) today announced the pricing of an upsized...

Global market projected to grow at a CAGR of 13.5% from 2026 to 2033 as pharmaceutical, food, and healthcare industries increasingly rely on advanced...

PARIS and NEW YORK and LONDON, June 25, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group ("AMTD IDEA")(NYSE: AMTD; SGX: HKB),...